Sometimes a client assigns GRG Health projects that are unique - besides requiring rapid turnaround and niche-based targeting they also require specialized domain knowledge.
Usually GRG Health receives such projects when there are significant changes or unprecedented events facing the industry from a client who hopes to find crucial answers well before they become common knowledge!
These are projects are more complex than usual and often focus on uniquely overlapping areas such as Cognitive decline and Heart disease.....or Antidepressant consumption and diminished Creativity, etc. So, to increase the chances of success, these projects are typically assigned to selected team members who are more experienced and either have the required knowledge or a strong learning curve!
Though these projects do not form the bulk of GRG Health's work, they are looked forward to eagerly. This is because so far, despite the extra bit of hard work and the extra bit of skilled research that was required, each of these projects has helped GRG Health leap forward by developing that extra bit of unique knowledge (in its team members)....and by delivering that extra bit of novel insights.....with an extra bit of "time advantage" vis-a-vis common knowledge (at that time), allowing GRG Health to deliver insights that eventually became breaking news a few quarters after the project was closed!
For example, one such project that was closed at least a year ago focused on the overlap between Cognitive decline and Heart disease. The project required GRG Health to conduct depth interviews with selected cardiologists in the US who were targeted on the basis of patient referrals to psychologists or psychaitrists (because of one or more patients' complaint regarding either cognitive decline or some kind of 'mental slowing').
Research conducted by GRG Health showed that though it was not documented widely enough, there was quite some volume of emerging concerns about this overlap, with one respondent stating the possibility that at least one out of every three patients admitted for a heart attack probably showed some level of cognitive decline after the event. Further, some of these respondents (cardiologists) also shared their concerns that though they did not have supporting data, they felt that certain popular medications which were regularly prescribed to cardiac patients may be potentially related to cognitive decline.....the respondents felt this way because some of their patients reported 'some signs' or asked about this problem while on the medication.
When GRG Health reported these insights to the client a year ago, it was received with some caution by the client who stated that available proof was anecdotal, not backed by well-documented/conducted studies.
However, today, it is great to see that situation changing - as more evidence emerges.....a year after GRG Health closed its project, confirming the overlap much before published research became available in enough volume!